Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Lipopolysaccharides (LPS) and Lipoteichoic Acid (LTA) are key components of bacterial cell membranes, found in Gram-negative and Gram-positive bacteria, respectively. LPS, located in the outer membrane of Gram-negative bacteria, consists of O-antigen, core polysaccharide, and Lipid A, and acts as a permeability barrier and potent immune stimulator. LTA, anchored in the cytoplasmic membrane of Gram-positive bacteria, is involved in cell wall maintenance, ion homeostasis, and modulation of host interactions. Both molecules are critical for bacterial survival and represent important targets for antimicrobial agents and immunomodulatory therapies. Variability in their structures allows bacteria to evade host immunity and develop resistance to antimicrobial agents.
Disruption of bacterial cell membrane; neutralization of endotoxic activity; inhibition of TLR signaling
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Lipopolysaccharides and Lipoteichoic Acid (LPS & LTA).